Page last updated: 2024-09-03

1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine and B16 Melanoma

1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collier, TL; Waterhouse, RN1

Other Studies

1 other study(ies) available for 1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine and B16 Melanoma

ArticleYear
In vivo evaluation of [18F]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a selective sigma-1 receptor radioligand for PET.
    Nuclear medicine and biology, 1997, Volume: 24, Issue:2

    Topics: Analysis of Variance; Animals; Brain; Chromatography, High Pressure Liquid; Fluorine Radioisotopes; Kidney; Liver; Lung; Male; Melanoma, Experimental; Mice; Mice, Nude; Muscle, Skeletal; Myocardium; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Tissue Distribution; Tomography, Emission-Computed

1997